Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis
Abstract Objective To assess the cost-effectiveness of cadonilimab plus chemotherapy compared to chemotherapy alone as first-line treatment for metastatic cervical cancer from the Chinaese medical healthcare perspective. Methods We developed a partitioned survival mode to simulate the costs and outc...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2025-12-01
|
| Σειρά: | BMC Health Services Research |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12913-025-13871-7 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|